Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

InMode Ltd. Ordinary Shares (INMD)

https://www.inmodemd.com

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/08/2019

Market Cap

1,362,367,510

Shares Outstanding

83,230,000

Weighted SO

83,231,630

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

TMDX --.--%

INSP --.--%

NARI --.--%

PODD --.--%

DXCM --.--%

EW --.--%

SWAV --.--%

SYK --.--%

BSX --.--%

Beta

2.1850

Last Div

0.0000

Range

15.62-40.4

Chg

0.1200

Avg Vol

1255982

Mkt Cap

1362367510

Exch

NASDAQ

Country

IL

Phone

972 4 909 6313

DCF Diff

-19.0972

DCF

35.0972

Div Yield

0.0000

P/S

3.2700

EV Multiple

9.4765

P/FV

1.7979

Div Yield %

0.0000

P/E

9.0512

PEG

0.6709

Payout

0.0000

Current Ratio

8.6293

Quick Ratio

8.0905

Cash Ratio

0.9417

DSO

53.5788

DIO

259.9972

Op Cycle

313.5760

DPO

76.8130

CCC

236.7630

Gross Margin

0.8227

Op Margin

0.3218

Pretax Margin

0.3951

Net Margin

0.3581

Eff Tax Rate

0.0936

ROA

0.1735

ROE

0.1939

ROCE

0.1759

NI/EBT

0.9064

EBT/EBIT

1.2279

EBIT/Rev

0.3218

Debt Ratio

0.0066

D/E

0.0076

LT Debt/Cap

0.0075

Total Debt/Cap

0.0075

Int Coverage

0.0000

CF/Debt

29.6850

Equity Multi

1.1447

Rec Turnover

6.8124

Pay Turnover

4.7518

Inv Turnover

1.4039

FA Turnover

35.7865

Asset Turnover

0.4845

OCF/Share

2.0070

FCF/Share

2.0007

Cash/Share

8.6937

OCF/Sales

0.4041

FCF/OCF

0.9969

CF Coverage

29.6850

ST Coverage

0.0000

CapEx Coverage

320.6144

Div&CapEx Cov

320.6144

P/BV

1.7979

P/B

1.7979

P/S

3.2700

P/E

9.0512

P/FCF

8.1181

P/OCF

8.0219

P/CF

8.0219

PEG

0.6709

P/S

3.2700

EV Multiple

9.4765

P/FV

1.7979

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Jan 07, 08:30 3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond The Motley Fool Jan 07, 08:30 3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond The Motley Fool Jan 07, 08:30 3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond The Motley Fool Jan 07, 08:30 3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond The Motley Fool Jan 07, 08:30 3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond The Motley Fool Jan 07, 08:30 3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond Zacks Investment Research Dec 29, 09:30 Is InMode (INMD) a Buy as Wall Street Analysts Look Optimistic? The Motley Fool Dec 06, 05:40 2 Small-Cap Stocks With Big Potential in 2024 The Motley Fool Dec 02, 08:10 2 Magnificent Stocks That Could Go Parabolic

Revenue Product Segmentation